Article
Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.
Antimicrobial agents and chemotherapy - 1 Aug 2014
Coen Natacha, Duraffour Sophie, Haraguchi Kazuhiro, Balzarini Jan, van den Oord Joost J, Snoeck Robert, Andrei Graciela
Abstract excerpt
The emergence of drug-resistant herpesviruses represents a significant problem in clinical practice, primarily in immunocompromised patients. Furthermore, effective antiviral therapies against gammaherpesvirus-associated diseases are lacking. Here, we present two thiothymidine derivatives, KAY-2-41 and KAH-39-149, with different spectra of antiviral activity from those of the reference antiherpetic drugs, showing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
